Tech Company Financing Transactions
Alzheon Funding Round
On 6/12/2017, Alzheon landed $15.8 million in investment from private investors.
Transaction Overview
Company Name
Announced On
6/12/2017
Transaction Type
Venture Equity
Amount
$15,764,099
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 63 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. Total Amount Sold also include the conversion of Promissory Notes. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
111 Speen St. 306
Framingham, MA 01701
USA
Framingham, MA 01701
USA
Phone
Website
Email Address
Not Recorded
Overview
Alzheon, Inc., is a clinical-stage biotechnology company focused on brain health, memory and aging, developing a pipeline of innovative.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Martin Tolar
Chief Medical Officer
Susan Abushakra
Chief Scientific Officer
John Hey
Vice President
Aidan Power
VP - Finance
Kenneth Mace
Browse more venture capital transactions:
Prev: 6/12/2017: Packagd venture capital transaction
Next: 6/12/2017: Eloxx Pharma venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on tech company VC transactions. All VC database entries on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs